BiotechTube
Defined Bioscience

Defined Bioscience

San Diego, United States· Est.
definedbioscience.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $59.5M

Overview

Defined Bioscience is a private, commercial-stage tools and reagents company founded in 2018 and headquartered in San Diego, California. It operates in the high-growth sectors of cell therapy and regenerative medicine by providing GMP-ready, chemically defined media and supporting reagents essential for stem cell research and biomanufacturing. The company serves a diverse customer base from academia to Fortune 500 companies, with a product portfolio centered on its HiDef® media line and thermostable FGF2-G3 growth factors. Its business model is based on product sales and custom formulation services, positioning it as an enabler for advanced therapeutic and cellular agriculture applications.

Cell TherapyRegenerative Medicine

Technology Platform

Proprietary formulations for serum-free, animal-free, and chemically defined cell culture media, growth factors (including thermostable FGF2-G3), and supplements for stem cell research and manufacturing.

Funding History

2
Total raised:$59.5M
Series A$55M
Seed$4.5M

Opportunities

The company is positioned at the convergence of two high-growth markets: cell therapy/biomanufacturing and cellular agriculture.
The global shift towards chemically defined, animal-free media is a dominant trend in both sectors, driven by regulatory and consistency demands.
Defined Bioscience's focus on cost-effective, scalable solutions addresses a primary bottleneck for widespread adoption, particularly in cultivated meat.

Risk Factors

Intense competition from large, established life science tools corporations with greater resources and market reach.
Growth is contingent on the funding health of the biotech sector and the successful commercialization of the cultivated meat industry.
As a smaller company, scaling manufacturing and protecting proprietary formulations from competition present ongoing challenges.

Competitive Landscape

Defined Bioscience competes in the cell culture media and reagents market against global giants like Thermo Fisher Scientific, Merck KGaA (MilliporeSigma), and Corning, as well as specialized players like STEMCELL Technologies and Fujifilm Irvine Scientific. Its differentiation is based on a dedicated focus on defined, animal-free formulations for stem cells and cultivated meat, competitive pricing, and thermostable growth factor technology.

More companies in Cell & Gene Therapy →More companies in United States →